Testing effectiveness (Phase 2)Study completedNCT05042973
What this trial is testing
The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure
Who this might be right for
ObesityHeart Failure
Jacob Moller 165
Showing 20 of 0 results